| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 2011 | A New Drug Design Targeting the Adenosinergic System for Huntington's Disease | Huang, N-K; Lin, J-H; Lin, J-T; Lin, C-I; Liu, E, M; Lin, C-J; Chen, W-P; Shen, Y-C; Chen, H-M; Chen, J-B; Lai, H-L; Yang, C-W; Chiang, C-M; Wu, Y-S; Chang, C; Chen, J-F; Fang, J-Mx; Lin, Y-Lx; Chern, Y | PLoS ONE 6, e20934 | | | |
| 2015 | Aberrant astrocytes impair vascular reactivity in Huntington disease | Hsiao, H-Y; Chen, Y-C; Huang, C-H; Chen, C-C; Hsu, Y-H; Chen, H-M; Chiu, F-L; Kuo, H-C; Chang, C; Chern, Y | Annals of Neurology 78(2), 178-192 | | | |
| 2014 | Adenosine Receptors in Neurology and Psychiatry-Adenosine receptor neurobiology: overview | Chen, J-F; Lee, C-F; Chern, Y | USA | | | |
| 2015 | AMPK-mediated regulation of neuronal metabolism and function in brain diseases | Liu, Y-J; Chern, Y | Journal of Neurogenetics 29(2-3), 50-58 | | | |
| 2015 | Conformational switch of polyglutamine-expanded huntingtin into benign aggregates leads to neuroprotective effect | Sun, C-S; Li, Y-N; Lin, C-H; Chang, Y-C; Liu, P-F; He, R-Y; Yang, S Y-C; Hsu, Y-C; Wang, C-H; Chen, W; Chern, Y; Huang, J J-T | Scientific Reports 5, 14992 | | | |
| 2011 | Dendritic trafficking of BDNF mRNA: regulation by translin-dependent and -independent mechanisms | Wu, Y; Williamson, R; Li, Z; Vicario, A; Xu, J; Kasai, M; Chern, Y; Tongiorgi, E; Baraban, J | Journal of Neurochemistry 116, 1112-1121 | | | |
| 2011 | Design and Synthesis of Novel Dual-Action Compounds Targeting Adenosine A2A Receptor and Adenosine Transporter for Neuroprotection. | Chen, J-B; Liu, EM; Chern, T-R; Yang, C-W; Lin, C-I; Huang, N-K; Lin, Y-L; Chern, Y; Lin, J-H; Fang, J-M. | ChemMedChem 6, 1390-1400 | | | |
| 2011 | Dysregulated brain-type creatine kinase contributes to hearing impairment in mice with Huntington’s disease. | Lin, Y-S; Chen, C-M; Soong, B-w; Wu, Y-R; Chen, H-M; Wu, D-R; Lin, Y-C; Wang, C-Hx; Chern, Y | Journal of Clinical Investigation 121, 1519-1523 | | | |
| 2015 | Effects on murine behavior and lifespan of selectively decreasing expression of mutant huntingtin allele by supt4h knockdown | Cheng, HM; Chern, Y; Chen, IH; Liu, CR; Li, SH; Chun, SJ; Rigo, F; Bennett, CF; Deng, N; Feng, Y; Lin, CS; Yan, YT; Cohen, SN; Cheng, TH | PLoS genetics 11(3), e1005043 | | | |
| 2015 | Elucidating the role of the A2A adenosine receptor in neurodegeneration using neurons derived from Huntington’s disease iPSCs | Chiu, F-L; Lin, J-T; Chuang, C-Y; Chien, T; Chen, C-M; Chen, K-H; Hsiao, H-Y; Lin, Y-S; Chern, Y; Kuo, HC | Human Molecular Genetics 24(21), 6066-6079 | | | |
| 2018 | GSK3β negatively regulates TRAX, a scaffold protein implicated in mental disorders, for NHEJ-mediated DNA repair in neurons. | Chien, T; Weng, YT; Chang, SY; Lai, HL; Chiu, FL; Kuo, HC; Chuang, DM; Chern, Y | Molecular psychiatry 23, 2375-2390 | | | |
| 2003 | Hydrogen peroxide induces loss of dopamine transporter activity: a calcium-dependent oxidative mechanism | Huang, CL; Huang, NK; Shyue, SK; Chern, Y | J Neurochem 86, 1247-1259 | | | |
| 2010 | Impaired water reabsorption in mice deficient in the type VI adenylyl cyclase (AC6). | Chien, C-L; Wu-Y-S; Lai, H-L; Chen, Y-H; Jiang, S-T; Shih, C-M; Lin, S-S; Chang, C; Chern, Y | FEBS LETTERS 584, 2883-2890 | | | |
| 2009 | Longitudinal evaluation of an N-ethyl-N-nitrosourea-created murine model with normal pressure hydrocephalus. | Lee, MJ; Chang, CP; Lee, YH; Wu, YC; Tseng, HW; Tung, YY; Wu, MT; Chen, YH; Kuo, LT; Stephenson, D; Hung, SI; Wu, JY; Chang, C; Chen, YT; Chern, Y | PloS one 4(11), e7868 | | | |
| 2010 | Magnetic Resonance Microscopic Angiography Visualization of Abnormal Microvasculature in a Transgenic Mouse Model of Huntington's Disease | Lin, C. Y; Huang, C. H; Lin, M. H; Hsu, Y. H; Tsai, C. R; Chen, H. M; Chern, Y; Chang, C. | | | | |
| 2010 | Modulation of energy deficiency in Huntington’s disease via activation of the peroxisome proliferator-activated receptor gamma. | Chiang, M-C; Chen, C-M; Lee, M-R; Chen, H-W; Chen, H-M; Wu, Y-S; Hung, C-H; Kang, J-J; chang, C-P; Chang, C; Wu, Y-R; Tsai, Y-S; Chern, Y | Human Molecular Genetics 19, 4043-4058 | | | |
| 2015 | Mutations in the ubiquitin-binding domain of OPTN/optineurin interfere with autophagy-mediated degradation of misfolded proteins by a dominant-negative mechanism | Shen, WC; Li, HY; Chen, GC; Chern, Y; Tu, PH | Autophagy 11(4), 685-700 | | | |
| 2009 | Novel regulation of adenylyl cyclases by direct protein-protein interactions: insights from Sanpin and Ric8a | Wang, S-C; Lin, J-T; Chern, Y | NeuroSignals 17(3), 169-180 | | | |
| 2011 | Nuclear translocation of AMP-activated protein kinase a1 potentiates striatal neurodegeneration in Huntington’s disease. Journal of Cell Biology 194: 209 - 227. | Ju, T-C; Chen, H-M; Lin, J-T; Chang, C-P; Chang, W-C; Kang, J-J; Sun, C-P; Tao, M-H; Tu, P-H; Chang, C; Dickson, DW; Chern, Y | JOURNAL OF CELL BIOLOGY 194, 209-227 | | | |
| 2012 | PPARgamma rescue of the mitochondrial dysfunction in Huntington's Disease. | Chiang, M-Cx; Chern, Y; Huang, R-N | Neurobiology of Disease 45, 322-328 | | | |
